FSM Wealth Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$580K Sell
24,073
-3,377
-12% -$88.3K 0.06% 168
2026
Q1
$771K Sell
27,450
-1,060
-4% -$28.2K 0.1% 117
2025
Q4
$710K Sell
28,510
-1,135
-4% -$28.6K 0.1% 121
2025
Q3
$755K Buy
29,645
+1,124
+4% +$27.7K 0.11% 116
2025
Q2
$720K Buy
28,521
+11,766
+70% +$274K 0.12% 111
2025
Q1
$425K Buy
16,755
+1,330
+9% +$34.8K 0.1% 120
2024
Q4
$409K Sell
15,425
-3,557
-19% -$96.5K 0.1% 114
2024
Q3
$549K Buy
18,982
+3,688
+24% +$108K 0.15% 87
2024
Q2
$428K Buy
15,294
+73
+0.5% +$2.01K 0.14% 92
2024
Q1
$422K Sell
15,221
-2,951
-16% -$81.9K 0.15% 94
2023
Q4
$523K Buy
18,172
+5
+0% +$151 0.22% 80
2023
Q3
$603K Sell
18,167
-480
-3% -$17K 0.3% 67
2023
Q2
$672K Buy
18,647
+50
+0.3% +$1.95K 0.34% 64
2023
Q1
$759K Buy
18,597
+1,277
+7% +$55.2K 0.44% 50
2022
Q4
$887K Sell
17,320
-2,384
-12% -$114K 0.63% 40
2022
Q3
$862K Buy
19,704
+6,939
+54% +$337K 0.72% 41
2022
Q2
$633K Buy
+12,765
New +$650K 0.63% 44

Other funds holding PFE

FSM Wealth Advisors's PFE Position: Q2 2026 in Review

FSM Wealth Advisors reduced its Pfizer (PFE) stake by 12% in Q2 2026, selling an estimated $88.3K and leaving 24,073 shares worth $580K. The position accounts for 0.06% of the portfolio, ranked #168.

FSM Wealth Advisors first reported a position in PFE in Q2 2022 and has held it in 17 quarters since. The position peaked at $887K in Q4 2022. 1,657 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • FSM Wealth Advisors held 24,073 shares of Pfizer worth $580K as of Q2 2026.
  • FSM Wealth Advisors sold 3,377 Pfizer shares in Q2 2026, an estimated $88.3K.
  • Pfizer made up 0.06% of FSM Wealth Advisors's portfolio in Q2 2026, its #168 holding.
  • FSM Wealth Advisors first reported a position in Pfizer in Q2 2022 and has held it in 17 quarters since.
  • FSM Wealth Advisors's Pfizer position peaked at $887K in Q4 2022.
  • 1,657 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on FSM Wealth Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.